MedCity News » Meghana Keshavan

Also, an FDA panel has rejected Sarepta Therapeutics’ Duchenne muscular dystrophy treatment, and Zimmer Biomet Holdings will acquire Cayenne Medical. The post Morning read: Ironwood Pharma bu...

https://medcitynews.com/2016/04/astrazeneca-gout-drug/

Valeant Pharmaceuticals just poached Perrigo CEO Joseph Papa to be its new chief executive. He’ll replace the somewhat reviled current CEO, Michael Pearson, in early May. The post Valeant...

https://medcitynews.com/2016/04/valeant-has-a-new-ceo-former-perrigo-chief-joseph-papa/

Every week, we compile the most trafficked and thoughtful stories on MedCity News. Most influential: A deeper dive into what athenahealth’s acquisition of Arsenal Health means for patient m...

https://medcitynews.com/2016/04/373105/

During a September 2015 keynote at Mayo Clinic’s Individualizing Medicine Conference, Venter was asked whether he had any interest in teaming up with the White House’s Precision Medicine Init...

https://medcitynews.com/2016/04/j-craig-venter/

Just about a year ago, Blueprint Medicines raised $169 million in Massachusetts’ largest biotech IPO. Today, it’s got three drugs in clinical trials – and, with a well-padded bank account, ...

https://medcitynews.com/2016/04/blueprint-medicines/

Working with J. Craig Venter’s Human Longevity Inc, the Wellcome Trust Sanger Institute and Finland’s Institute for Molecular Medicine, AstraZeneca — and its biologics R&D arm MedImmune —...

https://medcitynews.com/2016/04/astrazeneca-j-craig-venter/

Avisa Pharma is focusing primarily on tuberculosis detection, with aims to develop a rapid, point-of-care test that could determine if a patient has the disease within 10 minutes. The post Avis...

https://medcitynews.com/2016/04/372992/

Also, Medtronic recalls nearly 10,000 battery backs for patient breathing monitors over heat damage risk and Alere loses half a billion dollars in value as investors fear Abbott’s acquisition w...

https://medcitynews.com/2016/04/auris-surgical-robots/

The company is developing a prostate cancer vaccine called ProstAtak that’s in Phase 3 development – though its gene-mediate cytotoxic approach could be applied to several other solid tumor c...

https://medcitynews.com/2016/04/372852/

Second Genome uses genomics, computational biology and phenotypic screening to identify the molecular mechanisms of the microbiome that cause disease. The post Pfizer, Roche join $42.6M round t...

https://medcitynews.com/2016/04/372834/

Twist Bioscience’s platform centers around scaling DNA synthesis, building genetic sequences out at a fraction of the price of what they’ve historically cost. The post On heels of Genome Co...

https://medcitynews.com/2016/04/372787/

The new Seattle-based firm Biomatics Capital Partners is led by Boris Nikolic, a science advisor to Bill Gates. It is raising $150 million. The post Science advisor to Bill Gates launches n...

https://medcitynews.com/2016/04/biomatics-capital-partners-bill-gates/

Theranos is now embroiled in a criminal investigation, the Wall Street Journal reported, with federal prosecutors questioning whether the beleaguered diagnostics company misled government off...

https://medcitynews.com/2016/04/theranos-criminal-probe/

Elizabeth Holmes, CEO of erstwhile diagnostics company Theranos, will finally reveal data about its secretive technology at the AACC conference this August. The post Elizabeth Holmes to finally...

https://medcitynews.com/2016/04/theranos-elizabeth-holmes-aacc/

Louisville startup Breath Diagnostics has developed technology to pick up cancer-related compounds that are exhaled in one’s breath. The post Best of INVEST: Breath Diagnostics detects cancer...

https://medcitynews.com/2016/04/best-of-invest-breath-diagnostics-detects-cancer-with-breath-tests/

Sparrow Pharmaceuticals won the therapeutics category as part of this year’s Best of INVEST awards. Corticosteroids are an important anti-inflammatory treatment agent for a variety of me...

https://medcitynews.com/2016/04/372508/

In a statement, LifeSci Advisors says it “is dedicated to transforming itself into a model for promoting gender diversity” in the industry. The post LifeSci Advisors in damage control, now ...

https://medcitynews.com/2016/04/lifesci-advisors/

Also, a reverse merger by Synta Pharmaceuticals and Madrigal Pharmaceuticals will create a company that focuses on non-alcoholic steatohepatitis and Kaiser Permanente has launched a biobank to de...

https://medcitynews.com/2016/04/merck-and-hepatitis-c-drug/

Indeed, the growth rate is supposed to increase each year through 2020, the report says – thanks largely to drugs targeting cancer. The post U.S. drug spend $310B in 2015 – and projecte...

https://medcitynews.com/2016/04/drug-spend/

A new IMS report found that the 2015 late phase pipeline includes 2,320 novel products – and projects that more than 200 new drugs will be approved by 2020. The post Infograph: What new d...

https://medcitynews.com/2016/04/new-drugs-ims-health/

Dr. Akhil Saklecha of Artiman Ventures spoke on camera at this week’s INVEST conference in Chicago about the healthcare business opportunities in Asia – and some of the challenges that ...

https://medcitynews.com/2016/04/launching-a-healthcare-startup-in-india-challenges-and-opportunities/

The organization’s all about generic drugs – but unlike, say, Martin Shkreli, Bloom’s big idea is to repurpose existing drugs and lessen the overall costs of healthcare. The post Cure...

https://medcitynews.com/2016/04/cures-within-reach-valeant/

“I’m a skeptic of public market valuations, but a true believer in biotechnology,” said Hans Hinrichs, managing director of Silicon Valley Bank’s Life Sciences and Healthcare Group. �...

https://medcitynews.com/2016/04/372147/

However, medical devices haven’t fared nearly as well. While biotech investment hit a 21-year high in 2015, medical device funding has dropped to just a quarter of healthcare dollars. The...

https://medcitynews.com/2016/04/372097/

Corporate venture investment has emerged as an important alternative to more traditional healthcare funding avenues. However, there’s still a dearth of information about their activity. T...

https://medcitynews.com/2016/04/corporate-venture-capital/

Also, Intel healthcare guru Eric Dishman has been selected to lead up the Precision Medicine Initiative. The post Morning Read: CMS has a new primary care initiative to give control back to the...

https://medcitynews.com/2016/04/cms-primary-care/

In the wake of its relationship with Martin Shkreli, KaloBios’ new CEO Cameron Durrant “wants to clean up the messy legacy and start afresh,” he said. The post KaloBios distancing itself ...

https://medcitynews.com/2016/04/371991/

GE Ventures and Mayo Clinic have teamed up to spin out a new software company, called, Vitruvian Networks, that focuses on bringing the “internet of things” to the cell and gene therapy s...

https://medcitynews.com/2016/04/371946/

Every week, we compile the most trafficked and thoughtful stories on MedCity News. Most influential: IBM Watson Health’s Anil Jain on issues like alert fatigue, its partnerships, and the be...

https://medcitynews.com/2016/04/371829/

Counsyl’s layoffs are in sales support, marketing, design and engineering. The post Peter Thiel-backed carrier screening upstart Counsyl lays off 27 employees appeared first on MedCity N...

https://medcitynews.com/2016/04/counsyl/